Sequana Medical NV
F:2SE
Sequana Medical NV
F:2SE
Price:
0.512
EUR
Market Closed
Market Cap:
€15.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sequana Medical NV
F:2SE
|
BE |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISP
|
CH |
|
E
|
electroCore, Inc.
F:43E
|
US |
|
G
|
Grupo Aeroportuario del Centro Norte SAB de CV
XMUN:G7A
|
MX |
|
S
|
Siemens AG
XMUN:SIE
|
DE |
|
D
|
Daito Trust Construction Co Ltd
XBER:4D7
|
JP |
|
S
|
Shanghai Electric Group Co Ltd
SWB:USR
|
CN |
|
S
|
Star7 SpA
F:EH2
|
IT |
|
Italian Exhibition Group SpA
MIL:IEG
|
IT |
Wall St Price Targets
2SE Price Targets Summary
Sequana Medical NV
Sequana Medical NV
Wall Street analysts forecast 2SE stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 2SE is 1.795 EUR with a low forecast of 1.27 EUR and a high forecast of 2.376 EUR.
Lowest Forecast
Price Target
1.27
EUR
148% Upside
Average Forecast
Price Target
1.795
EUR
251% Upside
Highest Forecast
Price Target
2.376
EUR
364% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2SE's stock price target?
Price Target
1.795
EUR
1.795
EUR
According to Wall Street analysts, the average 1-year price target for 2SE is 1.795 EUR with a low forecast of 1.27 EUR and a high forecast of 2.376 EUR.
What is the Revenue forecast for Sequana Medical NV?
Projected CAGR
462%
462%
Over the last 8 years, the compound annual growth rate for Revenue has been -28%. The projected CAGR for the next 3 years is 462%.
